Strength at Home Program for Domestic Violence
Trial Summary
What is the purpose of this trial?
Intimate partner violence (IPV), specifically physical and psychological aggression toward an intimate partner, represents a public health crisis that affects millions of Americans each year. There currently exists very little evidence from randomized controlled trials for the effectiveness of abuser intervention programs designed to prevent and end perpetration of IPV in the general population. This is troubling considering that approximately half a million men and women are court-mandated to these programs each year. The investigators will conduct a randomized control trial (RCT) investigating the efficacy of the Strength at Home (SAH) intervention in reducing intimate partner violence (IPV). The overarching aim of this study is to test the efficacy of SAH with court-involved-partner-violent men through an RCT comparing those who receive SAH with those who receive other standard IPV interventions offered in the state of Washington (treatment as usual- TAU). The specific aims are: 1.1: Compare the frequency of physical and psychological IPV, the primary outcomes of interest, across conditions as reported by the male participants and their intimate partners across Time 1 (baseline) and four 3-month follow ups (Times 2-5). It is expected that greater reductions in IPV frequencies will be evidenced in SAH than TAU over the course of the year. 1.2: Compare symptoms of PTSD, alexithymia, and alcohol use problems across conditions and assessment time points as reported by the male participants. It is expected that greater reductions in these symptoms will be evidenced in SAH than TAU over the course of the year. 1.3: Compare treatment satisfaction across conditions as reported by the male participants across the four 3-month follow ups (Times 2-5). It is expected that treatment satisfaction will be higher in SAH than TAU.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Strength at Home (SAH) for domestic violence?
Research shows that the Strength at Home (SAH) program, a trauma-informed group treatment, has been implemented by the U.S. Department of Veterans Affairs to help reduce intimate partner violence (IPV) among veterans. Previous studies have provided evidence of SAH's effectiveness in reducing IPV, particularly in military and veteran populations.12345
What makes the Strength at Home treatment unique for intimate partner violence?
Strength at Home is unique because it is a trauma-informed, cognitive-behavioral group treatment specifically designed for military veterans and service members to reduce intimate partner violence. It focuses on addressing trauma and uses a social information processing model, which is not commonly found in traditional IPV treatments.12356
Research Team
Casey Taft, PhD
Principal Investigator
BU School of Medicine and National Center for PTSD
Eligibility Criteria
This trial is for men court-referred for intimate partner violence (IPV) intervention in Washington state who consent to partner contact. It also includes women who are or were partners involved in IPV incidents with these men.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Strength at Home (SAH) intervention or Treatment as Usual (TAU) for intimate partner violence
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Strength at Home (SAH)
- Treatment as usual for IPV
Strength at Home (SAH) is already approved in United States for the following indications:
- Intimate Partner Violence (IPV) prevention and treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
Office of Crime Victims Advocacy - Washington State Department of Commerce
Collaborator